Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1978 2
1983 1
1985 2
1987 1
1988 1
1990 1
1991 1
1992 1
1993 1
2000 1
2001 1
2004 1
2007 2
2012 1
2015 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pituitary gland acidophil adenoma"
Page 1
Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.
Gomez-Hernandez K, Ezzat S, Asa SL, Mete Ö. Gomez-Hernandez K, et al. Turk Patoloji Derg. 2015;31 Suppl 1:4-17. doi: 10.5146/tjpath.2015.01311. Turk Patoloji Derg. 2015. PMID: 26177314 Free article. Review.
For instance, silent subtype 3 pituitary adenomas, silent corticotroph adenomas, acidophil stem cell adenomas, Crooke cell adenomas, and sparsely granulated somatotroph adenomas show more invasive growth. This review has been formulated as a set of practical questio …
For instance, silent subtype 3 pituitary adenomas, silent corticotroph adenomas, acidophil stem cell adenomas, Crooke cell ade …
Silent pituitary plurihormonal adenoma: clinical relevance of immunohistochemical analysis.
García-Sáenz M, Uribe-Cortés D, González-Virla B, Mendoza-Zubieta V, Vargas-Ortega G. García-Sáenz M, et al. Rev Med Inst Mex Seguro Soc. 2019 Apr 1;57(1):48-55. Rev Med Inst Mex Seguro Soc. 2019. PMID: 31071255 English, Spanish.
In 2017 the World Health Organization recognized clinically aggressive adenomas as "high-risk pituitary adenomas". These include the sparsely granulated somatotroph adenoma, the Crooke's cell adenoma, the silent corticotroph adenoma and the plurihormon …
In 2017 the World Health Organization recognized clinically aggressive adenomas as "high-risk pituitary adenomas". These include the …
Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests.
Yoshino A, Katayama Y, Watanabe T, Ogino A, Ohta T, Komine C, Yokoyama T, Fukushima T, Hirota H. Yoshino A, et al. Acta Neurochir (Wien). 2007 Jun;149(6):557-65; discussion 565. doi: 10.1007/s00701-007-1155-8. Epub 2007 Apr 30. Acta Neurochir (Wien). 2007. PMID: 17468811 Review.
Pituitary apoplexy occurs as a very rare complication of the pituitary function test. ...Further, MRI, especially enhanced studies, may provide an earlier diagnosis of the pituitary apoplexy since CT scan images often fail to demonstrate either density change …
Pituitary apoplexy occurs as a very rare complication of the pituitary function test. ...Further, MRI, especially enhanced stu …
Epidemiology and biomarker profile of pituitary adenohypophysial tumors.
Mete O, Cintosun A, Pressman I, Asa SL. Mete O, et al. Mod Pathol. 2018 Jun;31(6):900-909. doi: 10.1038/s41379-018-0016-8. Epub 2018 Feb 12. Mod Pathol. 2018. PMID: 29434339 Free article.
Recent studies have reported the prevalence of pituitary tumors to be ~1/1000 population. Many are prolactin-producing tumors that are managed medically, however, the epidemiology of surgically resected pituitary adenohypophysial neuroendocrine tumors has not been r …
Recent studies have reported the prevalence of pituitary tumors to be ~1/1000 population. Many are prolactin-producing tumors that ar …
Pituitary carcinoma: an ultrastructural study of eleven cases.
Scheithauer BW, Fereidooni F, Horvath E, Kovacs K, Robbins P, Tews D, Henry K, Pernicone P, Gaffrey TA Jr, Meyer FB, Young WF Jr, Fahlbusch R, Buchfelder M, Lloyd RV. Scheithauer BW, et al. Ultrastruct Pathol. 2001 May-Jun;25(3):227-42. doi: 10.1080/019131201300343865. Ultrastruct Pathol. 2001. PMID: 11465479
Pituitary carcinomas are very rare. Defined as adenohypophysial tumors that undergo craniospinal and/or systemic metastasis, most are PRL- or ACTH-producing. ...Despite the diagnostic utility of electron microscopy in the assessment of these rare tumors, the distinction of …
Pituitary carcinomas are very rare. Defined as adenohypophysial tumors that undergo craniospinal and/or systemic metastasis, most are …
Ectopic growth hormone-releasing adenoma in the cavernous sinus--case report.
Mitsuya K, Nakasu Y, Nioka H, Nakasu S. Mitsuya K, et al. Neurol Med Chir (Tokyo). 2004 Jul;44(7):380-5. doi: 10.2176/nmc.44.380. Neurol Med Chir (Tokyo). 2004. PMID: 15347217 Free article. Review.
A 55-year-old woman presented a rare ectopic pituitary adenoma in the right cavernous sinus manifesting as acromegaly. The tumor was removed via transsphenoidal approach. Intraoperative observation showed the adenoma was located entirely within the rig …
A 55-year-old woman presented a rare ectopic pituitary adenoma in the right cavernous sinus manifesting as acromegaly. The tum …
Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture.
Ishibashi M, Fukushima T, Yamaji T. Ishibashi M, et al. Acta Endocrinol (Copenh). 1985 Aug;109(4):474-80. doi: 10.1530/acta.0.1090474. Acta Endocrinol (Copenh). 1985. PMID: 2994332
The effect of cyproheptadine on growth hormone (GH) and prolactin (Prl) secretion from cultured pituitary adenoma cells of acromegaly and pituitary gigantism was studied. ...In pituitary adenomas which concurrently produced and secreted Prl, cyprohepta …
The effect of cyproheptadine on growth hormone (GH) and prolactin (Prl) secretion from cultured pituitary adenoma cells of acr …
The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ, Liuzzi A. Lamberts SW, et al. Acta Endocrinol (Copenh). 1983 Aug;103(4):446-50. doi: 10.1530/acta.0.1030446. Acta Endocrinol (Copenh). 1983. PMID: 6310918
Surgically obtained pituitary tumour tissue from 35 consecutive acromegalic patients was studied immunohistochemically. ...The plasma Prl level is of value to predict which patients with acromegaly are likely to respond to bromocriptine with an inhibition of GH secr …
Surgically obtained pituitary tumour tissue from 35 consecutive acromegalic patients was studied immunohistochemically. ...The plasma …
Dedifferentiation and invasive growth of an eosinophil pituitary adenoma.
Ostertag C, Weitbrecht WU. Ostertag C, et al. Acta Neurochir (Wien). 1978;40(1-2):175-9. doi: 10.1007/BF01773125. Acta Neurochir (Wien). 1978. PMID: 207157
This report concerns the course of an eosinophil pituitary adenoma in an acromegalic female (16 years of age when first symptoms appeared) over a period of ten years. ...After several operations, dedifferentiation, and invasive growth into the orbit and the petrous …
This report concerns the course of an eosinophil pituitary adenoma in an acromegalic female (16 years of age when first sympto …
Goldmann perimetry in acromegaly: a survey of 307 cases from 1951 through 1996.
Rivoal O, Brézin AP, Feldman-Billard S, Luton JP. Rivoal O, et al. Ophthalmology. 2000 May;107(5):991-7. doi: 10.1016/s0161-6420(00)00060-9. Ophthalmology. 2000. PMID: 10811095
OBJECTIVE: Because visual pathway lesions are a common complication of pituitary tumors, visual field examinations in patients with acromegaly were studied. ...RESULTS: Of the 307 patients included in the analysis, a visual field defect that could be attributed to the p …
OBJECTIVE: Because visual pathway lesions are a common complication of pituitary tumors, visual field examinations in patients with a …
21 results